Literature DB >> 15356136

Unraveling the consecutive recombination events in the human IGK locus.

Anton W Langerak1, Bertrand Nadel, Anneke De Torbal, Ingrid L M Wolvers-Tettero, Ellen J van Gastel-Mol, Brenda Verhaaf, Ulrich Jäger, Jacques J M van Dongen.   

Abstract

In addition to the classical Vkappa-Jkappa, Vkappa-kappa deleting element (Kde), and intron-Kde gene rearrangements, atypical recombinations involving Jkappa recombination signal sequence (RSS) or intronRSS elements can occur in the Igkappa (IGK) locus, as observed in human B cell malignancies. In-depth analysis revealed that atypical JkappaRSS-intronRSS, Vkappa-intronRSS, and JkappaRSS-Kde recombinations not only occur in B cell malignancies, but rather reflect physiological gene rearrangements present in normal human B cells as well. Excision circle analysis and recombination substrate assays can discriminate between single-step vs multistep rearrangements. Using this combined approach, we unraveled that the atypical Vkappa-intronRSS and JkappaRSS-Kde pseudohybrid joints most probably result from ongoing recombination following an initial aberrant JkappaRSS-intronRSS signal joint formation. Based on our observations in normal and malignant human B cells, a model is presented to describe the sequential (classical and atypical) recombination events in the human IGK locus and their estimated relative frequencies (0.2-1.0 vs < 0.03). The initial JkappaRSS-intronRSS signal joint formation (except for Jkappa1RSS-intronRSS) might be a side event of an active V(D)J recombination mechanism, but the subsequent formation of Vkappa-intronRSS and JkappaRSS-Kde pseudohybrid joints can represent an alternative pathway for IGK allele inactivation and allelic exclusion, in addition to classical Ckappa deletions. Although usage of this alternative pathway is limited, it seems essential for inactivation of those IGK alleles that have undergone initial aberrant recombinations, which might otherwise hamper selection of functional Ig L chain proteins. Copyright 2004 The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15356136     DOI: 10.4049/jimmunol.173.6.3878

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Genomic organization and evolution of immunoglobulin kappa gene enhancers and kappa deleting element in mammals.

Authors:  Sabyasachi Das; Nikolas Nikolaidis; Masatoshi Nei
Journal:  Mol Immunol       Date:  2009-06-26       Impact factor: 4.407

2.  IL-7R expression and IL-7 signaling confer a distinct phenotype on developing human B-lineage cells.

Authors:  Sonja E Nodland; Magdalena A Berkowska; Anna A Bajer; Nisha Shah; Dick de Ridder; Jacques J M van Dongen; Tucker W LeBien; Menno C van Zelm
Journal:  Blood       Date:  2011-06-16       Impact factor: 22.113

3.  Clonal origins of ETV6-RUNX1⁺ acute lymphoblastic leukemia: studies in monozygotic twins.

Authors:  D Alpar; D Wren; L Ermini; M B Mansur; F W van Delft; C M Bateman; I Titley; L Kearney; T Szczepanski; D Gonzalez; A M Ford; N E Potter; M Greaves
Journal:  Leukemia       Date:  2014-11-12       Impact factor: 11.528

Review 4.  B cell receptor editing in tolerance and autoimmunity.

Authors:  Eline T Luning Prak; Marc Monestier; Robert A Eisenberg
Journal:  Ann N Y Acad Sci       Date:  2011-01-05       Impact factor: 5.691

Review 5.  Survival of the fetus: fetal B and T cell receptor repertoire development.

Authors:  Erez Rechavi; Raz Somech
Journal:  Semin Immunopathol       Date:  2017-05-02       Impact factor: 9.623

6.  A new type of radiosensitive T-B-NK+ severe combined immunodeficiency caused by a LIG4 mutation.

Authors:  Mirjam van der Burg; Lieneke R van Veelen; Nicole S Verkaik; Wouter W Wiegant; Nico G Hartwig; Barbara H Barendregt; Linda Brugmans; Anja Raams; Nicolaas G J Jaspers; Malgorzata Z Zdzienicka; Jacques J M van Dongen; Dik C van Gent
Journal:  J Clin Invest       Date:  2005-12-15       Impact factor: 14.808

7.  Violations of the 12/23 rule at the mouse immunoglobulin kappa locus, including V kappa-V kappa rearrangement.

Authors:  Jeffrey M Vinocur; Andrew D Fesnak; Yang Liu; Deepshikha Charan; Eline T Luning Prak
Journal:  Mol Immunol       Date:  2009-05-20       Impact factor: 4.407

8.  New insights on human T cell development by quantitative T cell receptor gene rearrangement studies and gene expression profiling.

Authors:  Willem A Dik; Karin Pike-Overzet; Floor Weerkamp; Dick de Ridder; Edwin F E de Haas; Miranda R M Baert; Peter van der Spek; Esther E L Koster; Marcel J T Reinders; Jacques J M van Dongen; Anton W Langerak; Frank J T Staal
Journal:  J Exp Med       Date:  2005-05-31       Impact factor: 14.307

9.  In vivo reinsertion of excised episomes by the V(D)J recombinase: a potential threat to genomic stability.

Authors:  Katrina Vanura; Bertrand Montpellier; Trang Le; Salvatore Spicuglia; Jean-Marc Navarro; Olivier Cabaud; Sandrine Roulland; Elodie Vachez; Immo Prinz; Pierre Ferrier; Rodrig Marculescu; Ulrich Jäger; Bertrand Nadel
Journal:  PLoS Biol       Date:  2007-03       Impact factor: 8.029

10.  Immunoglobulin light chain (IgL) genes in zebrafish: Genomic configurations and inversional rearrangements between (V(L)-J(L)-C(L)) gene clusters.

Authors:  Anastasia M Zimmerman; Gene Yeo; Kerstin Howe; Benjamin J Maddox; Lisa A Steiner
Journal:  Dev Comp Immunol       Date:  2007-09-20       Impact factor: 3.636

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.